Cargando…

Clinicopathological features and outcome for neuroendocrine neoplasms of gastroesophageal junction: A population‐based study

BACKGROUND: Gastroesophageal Junction neuroendocrine neoplasms (GEJ‐NENs) are rare and heterogeneous tumors. We aim to analyze the clinicopathlogical features and prognostic factors of GEJ‐NENs and to compare the outcome of GEJ‐NENs with other gastric NENs. METHODS: A total of 297 GEJ‐NENs patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Panpan, Wang, Wei, Lu, Ming, Zeng, Changqing, Chen, Jie, Li, Enxiao, Tan, Huangying, Yu, Xianjun, Tang, Qiyun, Zhao, Jiemin, Shen, Lin, Li, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143924/ https://www.ncbi.nlm.nih.gov/pubmed/30062861 http://dx.doi.org/10.1002/cam4.1702

Ejemplares similares

Clinicopathological features and lymph node and distant metastasis patterns in patients with gastroenteropancreatic mixed neuroendocrine‐non‐neuroendocrine neoplasm
por: Zhang, Panpan, et al.
Publicado: (2021)

Clinicopathological features and prognostic validity of the European Neuroendocrine Tumor Society (ENETS) and American Joint Committee on Cancer (AJCC) 8th staging systems in colonic neuroendocrine neoplasms
por: Zhang, Yu, et al.
Publicado: (2019)

Clinicopathological Features and Prognostic Factors of Colorectal Neuroendocrine Neoplasms
por: Jiang, Mengjie, et al.
Publicado: (2017)

Clinicopathological features, endoscopic features, and treatment analysis of gastric neuroendocrine neoplasms
por: Huang, Ju, et al.
Publicado: (2022)

Clinicopathologic and Molecular Features of Mixed Neuroendocrine Non-Neuroendocrine Neoplasms of the Gallbladder
por: Alawad, Mouyed, et al.
Publicado: (2020)

The Mutational, Prognostic, and Therapeutic Landscape of Neuroendocrine Neoplasms
por: Liu, Man, et al.
Publicado: (2023)

Neuroendocrine Neoplasms in Rare Locations: Clinicopathological Features and Review of the Literature
por: del Arco, Cristina Díaz, et al.
Publicado: (2018)

Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China
por: Fang, Cheng, et al.
Publicado: (2017)

Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms
por: Han, Deng, et al.
Publicado: (2021)

Clinicopathological features and prognostic validity of WHO grading classification of SI-NENs
por: Chen, Luohai, et al.
Publicado: (2017)

Clinicopathological features and prognosis of patients with gastric neuroendocrine tumors: A population‐based study
por: Tian, Fang‐Xi, et al.
Publicado: (2018)

Clinicopathological features and prognostic factors associated with gastroenteropancreatic mixed neuroendocrine non-neuroendocrine neoplasms in Chinese patients
por: Huang, Yu-Chen, et al.
Publicado: (2021)

Anlotinib Combined with Toripalimab as Second-Line Therapy for Advanced, Relapsed Gastric or Gastroesophageal Junction Carcinoma
por: Jiang, Man, et al.
Publicado: (2022)

Conditional survival in patients with esophageal or gastroesophageal junction cancer after receiving various treatment modalities
por: Deng, Wei, et al.
Publicado: (2020)

Case series of ovarian neuroendocrine carcinoma: overview of clinicopathological features
por: Feng, Bao-Jie, et al.
Publicado: (2023)

Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms
por: Koenig, Alexander, et al.
Publicado: (2017)

Clinicopathological Spectrum of Primary and Metastatic Neuroendocrine Neoplasms
por: Hashmi, Atif A, et al.
Publicado: (2020)

FGFR2‐Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic Landscape
por: Klempner, Samuel J., et al.
Publicado: (2019)

HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population
por: Shan, Ling, et al.
Publicado: (2013)

Association of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas
por: Pellino, Antonio, et al.
Publicado: (2021)

Positioning of second‐line treatment for advanced gastric and gastroesophageal junction adenocarcinoma
por: Pericay, Carles, et al.
Publicado: (2016)

Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction
por: Bornschein, Jan, et al.
Publicado: (2019)

Genomic dissection of gastrointestinal and lung neuroendocrine neoplasm
por: Wang, Haixing, et al.
Publicado: (2019)

Clinicopathological characteristics of rectal multiple neuroendocrine neoplasms and literature review
por: Zheng, Xiuli, et al.
Publicado: (2023)

Incidence trends of lung and gastroenteropancreatic neuroendocrine neoplasms in Switzerland
por: Alwan, Heba, et al.
Publicado: (2020)

Treatment for metastatic adenocarcinoma of the stomach and gastroesophageal junction: 2020
por: Hsu, Andrew, et al.
Publicado: (2020)

Association between MGMT status and response to alkylating agents in patients with neuroendocrine neoplasms: a systematic review and meta-analysis
por: Qi, Zhirong, et al.
Publicado: (2020)

Age‐specific clinicopathological characteristics and prognostic analysis of neuroendocrine carcinomas of the gallbladder
por: Zhang, Zhiwei, et al.
Publicado: (2021)

Clinicopathological parameters for predicting non-invasive follicular thyroid neoplasm with papillary features (NIFTP)
por: Jang, Eunju, et al.
Publicado: (2021)

Evaluation of Tumor DNA Sequencing Results in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma Stratified by TP53 Mutation Status
por: Wood, Anthony C, et al.
Publicado: (2022)

Clinicopathological features and menin expression of pancreatic neuroendocrine neoplasm associated with multiple endocrine neoplasia type 1
por: Sonoda, Akari, et al.
Publicado: (2020)

Neuroendocrine neoplasm of the gallbladder: Clinical features, surgical efficacy, and prognosis
por: Wu, Xin, et al.
Publicado: (2023)

Feature Review Papers on Gastroesophageal Junction and Gastric Cancers
por: Gronnier, Caroline
Publicado: (2022)

Pattern and risk factors for distant metastases in gastrointestinal neuroendocrine neoplasms: a population‐based study
por: Cai, Wen, et al.
Publicado: (2018)

Everolimus-Induced Pneumonitis in Patients with Neuroendocrine Neoplasms: Real-World Study on Risk Factors and Outcomes
por: Taboada, Rodrigo G, et al.
Publicado: (2022)

Clinicopathologic Features of Lymphoproliferative Neoplasms Involving the Liver
por: Chiang, I, et al.
Publicado: (2022)

Development and validation of prognostic nomograms for patients with colon neuroendocrine neoplasms
por: Xu, Ruitong, et al.
Publicado: (2021)

Analysis of the Clinicopathological Characteristics, Prognosis, and Lymphocyte Infiltration of Esophageal Neuroendocrine Neoplasms: A Surgery-Based Cohort and Propensity-Score Matching Study
por: Zhang, Long, et al.
Publicado: (2023)

Clinical Practice Observation of Trastuzumab in Patients with Human Epidermal Growth Receptor 2‐Positive Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
por: Al‐Batran, Salah‐Eddin, et al.
Publicado: (2020)

Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
por: Catenacci, Daniel V., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3p9ajke74211nf77kspvjpjlda